PRELP, collagen, and a theory of Hutchinson-Gilford progeria
- PMID: 12437997
- DOI: 10.1016/s1568-1637(02)00044-2
PRELP, collagen, and a theory of Hutchinson-Gilford progeria
Abstract
Proline/arginine-rich end leucine-rich repeat protein (PRELP) a small leucine-rich proteoglycan (SLRP), binds type I collagen to basement membranes and type II collagen to cartilage. Evidence for lack of binding of collagen in basement membranes and cartilage of Hutchinson-Gilford progeria (HGP) cases suggests PRELP involvement in that disease. PRELP deficiency is able to account for many symptoms of HGP. Moreover, PRELP also accounts for the fact that unlike many other collagen-related diseases, HGP symptoms are not congenital. The appearance of PRELP sometime after the third month of the birth, coincides with the appearance of HGP symptoms. Hutchinson-Gilford progeria has been diagnosed in twins with a chromosomal inversion at, or very near, the site of the PRELP gene.
Similar articles
-
The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor.J Biol Chem. 2002 Apr 26;277(17):15061-8. doi: 10.1074/jbc.M108285200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847210
-
Small leucine rich repeat proteoglycans (SLRPs) in the human sclera: identification of abundant levels of PRELP.Mol Vis. 2006 Sep 13;12:1057-66. Mol Vis. 2006. PMID: 17093390
-
PRELP (proline/arginine-rich end leucine-rich repeat protein) promotes osteoblastic differentiation of preosteoblastic MC3T3-E1 cells by regulating the β-catenin pathway.Biochem Biophys Res Commun. 2016 Feb 12;470(3):558-562. doi: 10.1016/j.bbrc.2016.01.106. Epub 2016 Jan 22. Biochem Biophys Res Commun. 2016. PMID: 26809092
-
Mechanisms of cardiovascular disease in accelerated aging syndromes.Circ Res. 2007 Jul 6;101(1):13-26. doi: 10.1161/CIRCRESAHA.107.153692. Circ Res. 2007. PMID: 17615378 Review.
-
Speeding up the clock: The past, present and future of progeria.Dev Growth Differ. 2016 Jan;58(1):116-30. doi: 10.1111/dgd.12251. Epub 2015 Dec 21. Dev Growth Differ. 2016. PMID: 26691051 Review.
Cited by
-
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.J Cell Biol. 2009 Nov 30;187(5):669-83. doi: 10.1083/jcb.200906014. J Cell Biol. 2009. PMID: 19951916 Free PMC article.
-
Therapeutic effects of PDGF-AB/BB against cellular senescence in human intervertebral disc.bioRxiv [Preprint]. 2025 Mar 27:2024.10.11.617862. doi: 10.1101/2024.10.11.617862. bioRxiv. 2025. Update in: Elife. 2025 Jul 16;13:RP103073. doi: 10.7554/eLife.103073. PMID: 39416006 Free PMC article. Updated. Preprint.
-
Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma.Front Med (Lausanne). 2024 Oct 23;11:1473080. doi: 10.3389/fmed.2024.1473080. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39507711 Free PMC article.
-
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer.Nat Commun. 2022 Oct 22;13(1):6292. doi: 10.1038/s41467-022-33991-6. Nat Commun. 2022. PMID: 36272973 Free PMC article.
-
Proteomic identification and validation of novel interactions of the putative tumor suppressor PRELP with membrane proteins including IGFI-R and p75NTR.J Biol Chem. 2021 Jan-Jun;296:100278. doi: 10.1016/j.jbc.2021.100278. Epub 2021 Jan 9. J Biol Chem. 2021. PMID: 33428936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources